- Home
- DGICB vs XOMA Comparison
DGICB vs XOMA Comparison
Compare DGICB & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICB
- XOMA
- Stock Information
- Founded
- DGICB 1986
- XOMA 1981
- Country
- DGICB United States
- XOMA United States
- Employees
- DGICB N/A
- XOMA N/A
- Industry
- DGICB Property-Casualty Insurers
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- DGICB Finance
- XOMA Health Care
- Exchange
- DGICB Nasdaq
- XOMA Nasdaq
- Market Cap
- DGICB 562.0M
- XOMA 457.6M
- IPO Year
- DGICB N/A
- XOMA N/A
- Fundamental
- Price
- DGICB $16.60
- XOMA $36.74
- Analyst Decision
- DGICB
- XOMA Strong Buy
- Analyst Count
- DGICB 0
- XOMA 2
- Target Price
- DGICB N/A
- XOMA $69.50
- AVG Volume (30 Days)
- DGICB 535.0
- XOMA 51.9K
- Earning Date
- DGICB 10-23-2025
- XOMA 11-06-2025
- Dividend Yield
- DGICB 3.83%
- XOMA N/A
- EPS Growth
- DGICB 965.80
- XOMA N/A
- EPS
- DGICB 2.34
- XOMA N/A
- Revenue
- DGICB $993,644,532.00
- XOMA $44,952,000.00
- Revenue This Year
- DGICB $2.26
- XOMA $88.91
- Revenue Next Year
- DGICB $2.96
- XOMA $13.80
- P/E Ratio
- DGICB $8.23
- XOMA N/A
- Revenue Growth
- DGICB 3.36
- XOMA 194.98
- 52 Week Low
- DGICB $12.00
- XOMA $18.35
- 52 Week High
- DGICB $20.46
- XOMA $38.34
- Technical
- Relative Strength Index (RSI)
- DGICB 61.63
- XOMA 66.37
- Support Level
- DGICB $15.10
- XOMA $33.59
- Resistance Level
- DGICB $16.95
- XOMA $38.34
- Average True Range (ATR)
- DGICB 0.11
- XOMA 1.64
- MACD
- DGICB 0.22
- XOMA -0.03
- Stochastic Oscillator
- DGICB 87.04
- XOMA 74.72
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.